Market Update (NYSE:BMY): Five Prime Therapeutics and Bristol-Myers Squibb Sign Collaboration Agreement to Discover Novel Immuno-Oncology Therapies for Two Immune Checkpoint Pathways

[at noodls] – “This strategic alliance is evidence that our protein discovery platform is ideally suited to identify novel immune checkpoint targets for the development of next generation immuno-oncology therapeutics.” … Read more . . . → Read More: Market Update (NYSE:BMY): Five Prime Therapeutics and Bristol-Myers Squibb Sign Collaboration Agreement to Discover Novel Immuno-Oncology Therapies for Two Immune Checkpoint Pathways Similar Articles: Stock Update (NYSE:BMY): U.S. FDA Approves Eliquis® (apixaban) To Reduce The Risk Of Blood Clots Following Hip Or Knee Replacement Surgery Lockheed Martin Corporation (NYSE:LMT) | Lockheed and AeroVironment sign agreement on drone development Stock Update: Google Inc (NASDAQ:GOOG) – Cisco and Google sign patent cross-licensing agreement